

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neuron cell-cell adhesion (GO:0007158) | 5.86042704 |
| 2 | vocalization behavior (GO:0071625) | 5.71355085 |
| 3 | synaptic vesicle exocytosis (GO:0016079) | 5.64075997 |
| 4 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.37128699 |
| 5 | protein localization to synapse (GO:0035418) | 5.21436251 |
| 6 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.21433782 |
| 7 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.91783667 |
| 8 | glutamate secretion (GO:0014047) | 4.82403067 |
| 9 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.77335762 |
| 10 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.73686660 |
| 11 | glutamate receptor signaling pathway (GO:0007215) | 4.66940103 |
| 12 | hepatocyte apoptotic process (GO:0097284) | 4.64945925 |
| 13 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 4.63236050 |
| 14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.59400327 |
| 15 | negative regulation of cell killing (GO:0031342) | 4.59400327 |
| 16 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.52950654 |
| 17 | neuron recognition (GO:0008038) | 4.52111774 |
| 18 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.50554492 |
| 19 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.46920504 |
| 20 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.43137217 |
| 21 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.40919167 |
| 22 | exploration behavior (GO:0035640) | 4.32279289 |
| 23 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.30001805 |
| 24 | regulation of platelet aggregation (GO:0090330) | 4.28741752 |
| 25 | response to histamine (GO:0034776) | 4.25611816 |
| 26 | positive regulation of synapse maturation (GO:0090129) | 4.24843708 |
| 27 | * neuron-neuron synaptic transmission (GO:0007270) | 4.21388897 |
| 28 | presynaptic membrane assembly (GO:0097105) | 4.17046867 |
| 29 | synaptic transmission, glutamatergic (GO:0035249) | 4.10891153 |
| 30 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.07770133 |
| 31 | locomotory exploration behavior (GO:0035641) | 4.02563702 |
| 32 | neuronal action potential propagation (GO:0019227) | 4.02082259 |
| 33 | regulation of synaptic vesicle transport (GO:1902803) | 4.01615206 |
| 34 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.01110604 |
| 35 | neutrophil activation involved in immune response (GO:0002283) | 3.88196144 |
| 36 | * regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.88145546 |
| 37 | neurotransmitter secretion (GO:0007269) | 3.86183241 |
| 38 | detection of molecule of bacterial origin (GO:0032490) | 3.86057287 |
| 39 | presynaptic membrane organization (GO:0097090) | 3.85747995 |
| 40 | axonal fasciculation (GO:0007413) | 3.83760783 |
| 41 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.83171455 |
| 42 | behavioral defense response (GO:0002209) | 3.79810030 |
| 43 | behavioral fear response (GO:0001662) | 3.79810030 |
| 44 | * regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.77734019 |
| 45 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.74737177 |
| 46 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.74509390 |
| 47 | regulation of beta-amyloid formation (GO:1902003) | 3.74401292 |
| 48 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.74280392 |
| 49 | postsynaptic membrane organization (GO:0001941) | 3.73920276 |
| 50 | fear response (GO:0042596) | 3.72907308 |
| 51 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.69976285 |
| 52 | protein K11-linked deubiquitination (GO:0035871) | 3.69753982 |
| 53 | melanin biosynthetic process (GO:0042438) | 3.69220273 |
| 54 | oxygen transport (GO:0015671) | 3.63943119 |
| 55 | * regulation of neuronal synaptic plasticity (GO:0048168) | 3.63023137 |
| 56 | * regulation of postsynaptic membrane potential (GO:0060078) | 3.62987992 |
| 57 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.62795800 |
| 58 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.62795800 |
| 59 | synaptic vesicle maturation (GO:0016188) | 3.59669259 |
| 60 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.59477696 |
| 61 | melanin metabolic process (GO:0006582) | 3.58550102 |
| 62 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.56780644 |
| 63 | neutrophil mediated immunity (GO:0002446) | 3.56677891 |
| 64 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.55164981 |
| 65 | positive regulation of granulocyte differentiation (GO:0030854) | 3.53265445 |
| 66 | regulation of vesicle fusion (GO:0031338) | 3.53097194 |
| 67 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.52286503 |
| 68 | mating behavior (GO:0007617) | 3.51847980 |
| 69 | long-term memory (GO:0007616) | 3.50101834 |
| 70 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.48657857 |
| 71 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.48657857 |
| 72 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.48657857 |
| 73 | modulation by symbiont of host immune response (GO:0052553) | 3.48657857 |
| 74 | positive regulation by symbiont of host defense response (GO:0052509) | 3.48657857 |
| 75 | modulation by symbiont of host defense response (GO:0052031) | 3.48657857 |
| 76 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.48460269 |
| 77 | * regulation of synaptic plasticity (GO:0048167) | 3.48411969 |
| 78 | detection of calcium ion (GO:0005513) | 3.47594697 |
| 79 | dendritic spine morphogenesis (GO:0060997) | 3.46577971 |
| 80 | proline transport (GO:0015824) | 3.45398178 |
| 81 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.44415000 |
| 82 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.44335008 |
| 83 | * long-term synaptic potentiation (GO:0060291) | 3.44056521 |
| 84 | myeloid leukocyte mediated immunity (GO:0002444) | 3.41908403 |
| 85 | positive regulation of membrane potential (GO:0045838) | 3.41166190 |
| 86 | regulation of synapse maturation (GO:0090128) | 3.40232340 |
| 87 | response to methylmercury (GO:0051597) | 3.38519425 |
| 88 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.37189805 |
| 89 | transmission of nerve impulse (GO:0019226) | 3.36257489 |
| 90 | transferrin transport (GO:0033572) | 3.36170573 |
| 91 | regulation of synapse structural plasticity (GO:0051823) | 3.35264372 |
| 92 | * microglial cell activation (GO:0001774) | 3.34691432 |
| 93 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.33834123 |
| 94 | response to amphetamine (GO:0001975) | 3.31853475 |
| 95 | positive T cell selection (GO:0043368) | 3.31771615 |
| 96 | * neurotransmitter transport (GO:0006836) | 3.30989278 |
| 97 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 3.30408346 |
| 98 | positive regulation of synapse assembly (GO:0051965) | 3.29512566 |
| 99 | layer formation in cerebral cortex (GO:0021819) | 3.29386452 |
| 100 | serotonin metabolic process (GO:0042428) | 3.27022109 |
| 101 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.22594609 |
| 102 | ATP synthesis coupled proton transport (GO:0015986) | 3.22594609 |
| 103 | regulation of dendritic spine development (GO:0060998) | 3.22332213 |
| 104 | myeloid cell development (GO:0061515) | 3.21181888 |
| 105 | female mating behavior (GO:0060180) | 3.20180580 |
| 106 | learning (GO:0007612) | 3.19689786 |
| 107 | regulation of mitochondrial depolarization (GO:0051900) | 3.18150321 |
| 108 | macrophage activation involved in immune response (GO:0002281) | 3.17969150 |
| 109 | innervation (GO:0060384) | 3.16283626 |
| 110 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.15614565 |
| 111 | regulation of female receptivity (GO:0045924) | 3.15337853 |
| 112 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.13385670 |
| 113 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.12885541 |
| 114 | * regulation of neurotransmitter levels (GO:0001505) | 3.10176089 |
| 115 | ferric iron transport (GO:0015682) | 3.09974972 |
| 116 | trivalent inorganic cation transport (GO:0072512) | 3.09974972 |
| 117 | * synaptic vesicle endocytosis (GO:0048488) | 3.09453378 |
| 118 | * synaptic vesicle transport (GO:0048489) | 3.09409928 |
| 119 | * establishment of synaptic vesicle localization (GO:0097480) | 3.09409928 |
| 120 | positive regulation of dendritic spine development (GO:0060999) | 3.08153796 |
| 121 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.07978516 |
| 122 | * behavioral response to cocaine (GO:0048148) | 3.07885768 |
| 123 | intraspecies interaction between organisms (GO:0051703) | 3.07746164 |
| 124 | social behavior (GO:0035176) | 3.07746164 |
| 125 | gas transport (GO:0015669) | 3.04740888 |
| 126 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.04334303 |
| 127 | synapse assembly (GO:0007416) | 3.04137834 |
| 128 | startle response (GO:0001964) | 3.02318073 |
| 129 | megakaryocyte development (GO:0035855) | 3.02021142 |
| 130 | * membrane depolarization (GO:0051899) | 3.01131330 |
| 131 | regulation of gamma-delta T cell activation (GO:0046643) | 3.00211659 |
| 132 | hemoglobin metabolic process (GO:0020027) | 2.99454425 |
| 133 | * synaptic transmission (GO:0007268) | 2.99217178 |
| 134 | * dopamine biosynthetic process (GO:0042416) | 2.98920621 |
| 135 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.98839915 |
| 136 | negative regulation of T cell mediated immunity (GO:0002710) | 2.98613169 |
| 137 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.98006579 |
| 138 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.98006579 |
| 139 | regulation of protein kinase A signaling (GO:0010738) | 2.97982770 |
| 140 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.97744128 |
| 141 | negative regulation of amino acid transport (GO:0051956) | 2.97011186 |
| 142 | * regulation of glutamate secretion (GO:0014048) | 2.96974117 |
| 143 | cochlea development (GO:0090102) | 2.96772654 |
| 144 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.96656105 |
| 145 | positive regulation of mast cell activation (GO:0033005) | 2.96038295 |
| 146 | activated T cell proliferation (GO:0050798) | 2.95706823 |
| 147 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.95450205 |
| 148 | * regulation of neurotransmitter secretion (GO:0046928) | 2.95347771 |
| 149 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.94648428 |
| 150 | long term synaptic depression (GO:0060292) | 2.94444964 |
| 151 | myeloid cell activation involved in immune response (GO:0002275) | 2.93079261 |
| 152 | B cell receptor signaling pathway (GO:0050853) | 2.92299059 |
| 153 | response to insecticide (GO:0017085) | 2.90388601 |
| 154 | positive thymic T cell selection (GO:0045059) | 2.88929605 |
| 155 | secondary metabolite biosynthetic process (GO:0044550) | 2.88003805 |
| 156 | cellular extravasation (GO:0045123) | 2.87884935 |
| 157 | negative T cell selection (GO:0043383) | 2.85396214 |
| 158 | histone mRNA catabolic process (GO:0071044) | 2.84153177 |
| 159 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.83442275 |
| 160 | erythrocyte development (GO:0048821) | 2.82641629 |
| 161 | detection of external biotic stimulus (GO:0098581) | 2.80431685 |
| 162 | neutrophil activation (GO:0042119) | 2.78663292 |
| 163 | regulation of platelet activation (GO:0010543) | 2.76760251 |
| 164 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.76436164 |
| 165 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.75483706 |
| 166 | response to host immune response (GO:0052572) | 2.75483706 |
| 167 | negative regulation of inclusion body assembly (GO:0090084) | 2.75233602 |
| 168 | * macrophage activation (GO:0042116) | 2.70118218 |
| 169 | negative thymic T cell selection (GO:0045060) | 2.68003815 |
| 170 | negative regulation of protein oligomerization (GO:0032460) | 2.67056074 |
| 171 | nerve growth factor signaling pathway (GO:0038180) | 2.66746954 |
| 172 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.66320018 |
| 173 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.65087794 |
| 174 | regulation of necroptotic process (GO:0060544) | 2.62695098 |
| 175 | leukocyte degranulation (GO:0043299) | 2.52556377 |
| 176 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.50165179 |
| 177 | negative regulation of B cell mediated immunity (GO:0002713) | 2.50165179 |
| 178 | negative regulation of interleukin-17 production (GO:0032700) | 2.48736180 |
| 179 | regulation of cellular amide metabolic process (GO:0034248) | 2.47493410 |
| 180 | detection of other organism (GO:0098543) | 2.45848512 |
| 181 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.44724699 |
| 182 | superoxide anion generation (GO:0042554) | 2.43311291 |
| 183 | clathrin coat assembly (GO:0048268) | 2.43260500 |
| 184 | negative regulation of B cell proliferation (GO:0030889) | 2.42599571 |
| 185 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.41122719 |
| 186 | granulocyte activation (GO:0036230) | 2.40494518 |
| 187 | cerebellar granule cell differentiation (GO:0021707) | 2.40287696 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.37083489 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.37087210 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.26618965 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.20130787 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.11960023 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.01563655 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.98611107 |
| 8 | GATA1_22025678_ChIP-Seq_K562_Human | 2.96939219 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.84755913 |
| 10 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.84389409 |
| 11 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.79816151 |
| 12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.68762698 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.58671720 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.58392261 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.58392261 |
| 16 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.57727930 |
| 17 | GATA1_19941826_ChIP-Seq_K562_Human | 2.56683796 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.53944603 |
| 19 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.53857330 |
| 20 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.43829857 |
| 21 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.39653116 |
| 22 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.38264070 |
| 23 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.37667313 |
| 24 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.37260057 |
| 25 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.35746733 |
| 26 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.31775804 |
| 27 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.25534000 |
| 28 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.19990495 |
| 29 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.17757987 |
| 30 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.17331466 |
| 31 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.12501214 |
| 32 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.11519332 |
| 33 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.11142184 |
| 34 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.08895697 |
| 35 | GATA2_19941826_ChIP-Seq_K562_Human | 2.06203340 |
| 36 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.05691217 |
| 37 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.01845665 |
| 38 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.00458011 |
| 39 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.00406454 |
| 40 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.00307592 |
| 41 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.99863173 |
| 42 | VDR_22108803_ChIP-Seq_LS180_Human | 1.99172022 |
| 43 | P300_19829295_ChIP-Seq_ESCs_Human | 1.93366722 |
| 44 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.90755914 |
| 45 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.90357785 |
| 46 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.89131254 |
| 47 | FUS_26573619_Chip-Seq_HEK293_Human | 1.88332682 |
| 48 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.87732386 |
| 49 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.86274116 |
| 50 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.86065555 |
| 51 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.85112478 |
| 52 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.81934788 |
| 53 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.80242715 |
| 54 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.79064750 |
| 55 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.78866551 |
| 56 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.78645411 |
| 57 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.76977019 |
| 58 | * IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.75822655 |
| 59 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.68311919 |
| 60 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.66497495 |
| 61 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.65121131 |
| 62 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.64611517 |
| 63 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.63369428 |
| 64 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.63061811 |
| 65 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.60115756 |
| 66 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59877419 |
| 67 | SPI1_23127762_ChIP-Seq_K562_Human | 1.59565240 |
| 68 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.59326380 |
| 69 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.57219179 |
| 70 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.53468778 |
| 71 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.53443037 |
| 72 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.53423270 |
| 73 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.46109809 |
| 74 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.45459135 |
| 75 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.44888570 |
| 76 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.44693088 |
| 77 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43767543 |
| 78 | AR_25329375_ChIP-Seq_VCAP_Human | 1.42998315 |
| 79 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.42460419 |
| 80 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.38618122 |
| 81 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.38438697 |
| 82 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.38291300 |
| 83 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.37268945 |
| 84 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.37115680 |
| 85 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.35594061 |
| 86 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.31452334 |
| 87 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.30675255 |
| 88 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.30478800 |
| 89 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.29896486 |
| 90 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.29587319 |
| 91 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.29439685 |
| 92 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.28639713 |
| 93 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.27671608 |
| 94 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.25776096 |
| 95 | JUN_21703547_ChIP-Seq_K562_Human | 1.24209475 |
| 96 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.21825754 |
| 97 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.21690865 |
| 98 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21101735 |
| 99 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.20631716 |
| 100 | MYB_26560356_Chip-Seq_TH2_Human | 1.20314243 |
| 101 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.19109404 |
| 102 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.18158924 |
| 103 | STAT3_23295773_ChIP-Seq_U87_Human | 1.17034602 |
| 104 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.15752161 |
| 105 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.14717464 |
| 106 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.14158760 |
| 107 | TCF4_23295773_ChIP-Seq_U87_Human | 1.14072721 |
| 108 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.13985895 |
| 109 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.13880145 |
| 110 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.13194738 |
| 111 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.13162720 |
| 112 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.12537982 |
| 113 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.12210298 |
| 114 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.11184857 |
| 115 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10453844 |
| 116 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.10309975 |
| 117 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.09992729 |
| 118 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.09511128 |
| 119 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.09167441 |
| 120 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.08554221 |
| 121 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08070957 |
| 122 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.07265554 |
| 123 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05565859 |
| 124 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.05565859 |
| 125 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.05212829 |
| 126 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.05104090 |
| 127 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.05001806 |
| 128 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.04941871 |
| 129 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.04266867 |
| 130 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.02915914 |
| 131 | EWS_26573619_Chip-Seq_HEK293_Human | 1.02652134 |
| 132 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.02068702 |
| 133 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.01345465 |
| 134 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.01176697 |
| 135 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.01143483 |
| 136 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00891557 |
| 137 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00804649 |
| 138 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.00054138 |
| 139 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99780815 |
| 140 | AR_19668381_ChIP-Seq_PC3_Human | 0.99485162 |
| 141 | KDM2B_26808549_Chip-Seq_REH_Human | 0.99146797 |
| 142 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.99119585 |
| 143 | GATA3_26560356_Chip-Seq_TH2_Human | 0.97124873 |
| 144 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.97045082 |
| 145 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.97012420 |
| 146 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.95860707 |
| 147 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95856226 |
| 148 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.95811759 |
| 149 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95737544 |
| 150 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.95278048 |
| 151 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.94198855 |
| 152 | * TP53_16413492_ChIP-PET_HCT116_Human | 0.94109791 |
| 153 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.93683498 |
| 154 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.92530674 |
| 155 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.91837882 |
| 156 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.91132254 |
| 157 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.89807817 |
| 158 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.89524407 |
| 159 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.88658328 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 6.09566787 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 5.66816816 |
| 3 | MP0003656_abnormal_erythrocyte_physiolo | 4.08560574 |
| 4 | * MP0003635_abnormal_synaptic_transmissio | 4.05383149 |
| 5 | MP0008260_abnormal_autophagy | 3.90674779 |
| 6 | MP0009745_abnormal_behavioral_response | 3.57537074 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.45623095 |
| 8 | MP0004270_analgesia | 3.20658112 |
| 9 | MP0005464_abnormal_platelet_physiology | 3.19182216 |
| 10 | MP0001968_abnormal_touch/_nociception | 3.18477293 |
| 11 | MP0002064_seizures | 3.14199415 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 3.00736501 |
| 13 | MP0000372_irregular_coat_pigmentation | 2.97798399 |
| 14 | MP0002736_abnormal_nociception_after | 2.97727692 |
| 15 | MP0005075_abnormal_melanosome_morpholog | 2.84795520 |
| 16 | MP0003724_increased_susceptibility_to | 2.83807884 |
| 17 | MP0002822_catalepsy | 2.81998655 |
| 18 | MP0004381_abnormal_hair_follicle | 2.77475932 |
| 19 | MP0009046_muscle_twitch | 2.71068703 |
| 20 | MP0005174_abnormal_tail_pigmentation | 2.67300587 |
| 21 | MP0001501_abnormal_sleep_pattern | 2.62926533 |
| 22 | MP0001440_abnormal_grooming_behavior | 2.57319497 |
| 23 | MP0002735_abnormal_chemical_nociception | 2.56074685 |
| 24 | MP0002272_abnormal_nervous_system | 2.52863688 |
| 25 | MP0006276_abnormal_autonomic_nervous | 2.52072905 |
| 26 | MP0001529_abnormal_vocalization | 2.48210962 |
| 27 | MP0002734_abnormal_mechanical_nocicepti | 2.39519425 |
| 28 | MP0003172_abnormal_lysosome_physiology | 2.37472870 |
| 29 | MP0003303_peritoneal_inflammation | 2.35703877 |
| 30 | MP0001486_abnormal_startle_reflex | 2.31030020 |
| 31 | * MP0001905_abnormal_dopamine_level | 2.23710117 |
| 32 | MP0002837_dystrophic_cardiac_calcinosis | 2.22194592 |
| 33 | MP0005423_abnormal_somatic_nervous | 2.08553030 |
| 34 | MP0008877_abnormal_DNA_methylation | 2.06952009 |
| 35 | MP0002733_abnormal_thermal_nociception | 2.00995965 |
| 36 | MP0003329_amyloid_beta_deposits | 1.99052384 |
| 37 | MP0000778_abnormal_nervous_system | 1.98848052 |
| 38 | MP0004147_increased_porphyrin_level | 1.98370607 |
| 39 | * MP0002067_abnormal_sensory_capabilities | 1.98314799 |
| 40 | MP0004924_abnormal_behavior | 1.97439252 |
| 41 | MP0005386_behavior/neurological_phenoty | 1.97439252 |
| 42 | MP0002184_abnormal_innervation | 1.92959858 |
| 43 | MP0001970_abnormal_pain_threshold | 1.92661429 |
| 44 | MP0001984_abnormal_olfaction | 1.85736672 |
| 45 | MP0005408_hypopigmentation | 1.83639411 |
| 46 | MP0001835_abnormal_antigen_presentation | 1.78283819 |
| 47 | MP0002557_abnormal_social/conspecific_i | 1.72662285 |
| 48 | MP0001188_hyperpigmentation | 1.71442854 |
| 49 | MP0002095_abnormal_skin_pigmentation | 1.63138731 |
| 50 | MP0009780_abnormal_chondrocyte_physiolo | 1.57135220 |
| 51 | MP0002909_abnormal_adrenal_gland | 1.54748964 |
| 52 | MP0003690_abnormal_glial_cell | 1.54251407 |
| 53 | * MP0004811_abnormal_neuron_physiology | 1.48195820 |
| 54 | MP0003879_abnormal_hair_cell | 1.46039947 |
| 55 | MP0000371_diluted_coat_color | 1.39992134 |
| 56 | * MP0002066_abnormal_motor_capabilities/c | 1.35877150 |
| 57 | MP0003121_genomic_imprinting | 1.33792817 |
| 58 | MP0005646_abnormal_pituitary_gland | 1.31247671 |
| 59 | MP0000465_gastrointestinal_hemorrhage | 1.29666983 |
| 60 | * MP0002882_abnormal_neuron_morphology | 1.29070223 |
| 61 | MP0003122_maternal_imprinting | 1.28643120 |
| 62 | MP0004883_abnormal_blood_vessel | 1.28049635 |
| 63 | * MP0000955_abnormal_spinal_cord | 1.27069925 |
| 64 | MP0005409_darkened_coat_color | 1.25721618 |
| 65 | MP0008569_lethality_at_weaning | 1.25150870 |
| 66 | MP0002332_abnormal_exercise_endurance | 1.24088818 |
| 67 | MP0003787_abnormal_imprinting | 1.21109319 |
| 68 | MP0001800_abnormal_humoral_immune | 1.21081249 |
| 69 | MP0002876_abnormal_thyroid_physiology | 1.20753827 |
| 70 | MP0008872_abnormal_physiological_respon | 1.20049475 |
| 71 | MP0004130_abnormal_muscle_cell | 1.17958313 |
| 72 | MP0002398_abnormal_bone_marrow | 1.17873269 |
| 73 | MP0001545_abnormal_hematopoietic_system | 1.17419743 |
| 74 | MP0005397_hematopoietic_system_phenotyp | 1.17419743 |
| 75 | MP0001502_abnormal_circadian_rhythm | 1.15678573 |
| 76 | MP0004142_abnormal_muscle_tone | 1.15101963 |
| 77 | MP0003763_abnormal_thymus_physiology | 1.14089175 |
| 78 | MP0002419_abnormal_innate_immunity | 1.11380548 |
| 79 | MP0008057_abnormal_DNA_replication | 1.11266184 |
| 80 | MP0005645_abnormal_hypothalamus_physiol | 1.11160887 |
| 81 | MP0003183_abnormal_peptide_metabolism | 1.08507309 |
| 82 | MP0010386_abnormal_urinary_bladder | 1.08025142 |
| 83 | MP0005499_abnormal_olfactory_system | 1.07148425 |
| 84 | MP0005394_taste/olfaction_phenotype | 1.07148425 |
| 85 | MP0003633_abnormal_nervous_system | 1.05707092 |
| 86 | MP0004858_abnormal_nervous_system | 1.05581051 |
| 87 | MP0005535_abnormal_body_temperature | 1.04977090 |
| 88 | MP0005083_abnormal_biliary_tract | 1.04895924 |
| 89 | * MP0002152_abnormal_brain_morphology | 1.02919912 |
| 90 | MP0002420_abnormal_adaptive_immunity | 1.02184784 |
| 91 | MP0001819_abnormal_immune_cell | 0.99628613 |
| 92 | MP0005671_abnormal_response_to | 0.99465878 |
| 93 | MP0005167_abnormal_blood-brain_barrier | 0.99379569 |
| 94 | MP0005000_abnormal_immune_tolerance | 0.99370254 |
| 95 | MP0004742_abnormal_vestibular_system | 0.99078914 |
| 96 | MP0004484_altered_response_of | 0.98942482 |
| 97 | MP0003866_abnormal_defecation | 0.98868760 |
| 98 | MP0000689_abnormal_spleen_morphology | 0.96902235 |
| 99 | MP0002723_abnormal_immune_serum | 0.96893704 |
| 100 | MP0004145_abnormal_muscle_electrophysio | 0.96658502 |
| 101 | MP0000751_myopathy | 0.94749977 |
| 102 | MP0003828_pulmonary_edema | 0.92729767 |
| 103 | * MP0003631_nervous_system_phenotype | 0.92441119 |
| 104 | MP0001851_eye_inflammation | 0.91490866 |
| 105 | MP0000604_amyloidosis | 0.90938651 |
| 106 | MP0005551_abnormal_eye_electrophysiolog | 0.90759094 |
| 107 | MP0002069_abnormal_eating/drinking_beha | 0.90125095 |
| 108 | MP0002722_abnormal_immune_system | 0.89453651 |
| 109 | MP0005310_abnormal_salivary_gland | 0.89331123 |
| 110 | MP0001963_abnormal_hearing_physiology | 0.88632728 |
| 111 | MP0002452_abnormal_antigen_presenting | 0.88061611 |
| 112 | MP0003221_abnormal_cardiomyocyte_apopto | 0.87685109 |
| 113 | MP0000716_abnormal_immune_system | 0.86944875 |
| 114 | MP0004085_abnormal_heartbeat | 0.86014723 |
| 115 | MP0009379_abnormal_foot_pigmentation | 0.85193504 |
| 116 | * MP0005025_abnormal_response_to | 0.83334415 |
| 117 | MP0003136_yellow_coat_color | 0.83013153 |
| 118 | MP0004885_abnormal_endolymph | 0.81853948 |
| 119 | MP0000013_abnormal_adipose_tissue | 0.80711192 |
| 120 | MP0000631_abnormal_neuroendocrine_gland | 0.80613432 |
| 121 | * MP0002229_neurodegeneration | 0.78138039 |
| 122 | MP0000703_abnormal_thymus_morphology | 0.78089386 |
| 123 | MP0004215_abnormal_myocardial_fiber | 0.77728235 |
| 124 | MP0002166_altered_tumor_susceptibility | 0.77617381 |
| 125 | MP0000920_abnormal_myelination | 0.77097190 |
| 126 | MP0003436_decreased_susceptibility_to | 0.76679521 |
| 127 | MP0002429_abnormal_blood_cell | 0.76213563 |
| 128 | MP0005171_absent_coat_pigmentation | 0.76029829 |
| 129 | MP0004808_abnormal_hematopoietic_stem | 0.75880834 |
| 130 | MP0008004_abnormal_stomach_pH | 0.75824529 |
| 131 | MP0000685_abnormal_immune_system | 0.75642145 |
| 132 | * MP0002752_abnormal_somatic_nervous | 0.75058680 |
| 133 | * MP0008874_decreased_physiological_sensi | 0.73357049 |
| 134 | MP0003300_gastrointestinal_ulcer | 0.72672435 |
| 135 | * MP0001664_abnormal_digestion | 0.67395265 |
| 136 | MP0000026_abnormal_inner_ear | 0.65087756 |
| 137 | MP0005379_endocrine/exocrine_gland_phen | 0.63053291 |
| 138 | MP0008789_abnormal_olfactory_epithelium | 0.60365077 |
| 139 | MP0006292_abnormal_olfactory_placode | 0.57525142 |
| 140 | MP0001177_atelectasis | 0.57217373 |
| 141 | MP0002102_abnormal_ear_morphology | 0.56610291 |
| 142 | MP0002090_abnormal_vision | 0.55714448 |
| 143 | MP0002163_abnormal_gland_morphology | 0.55528620 |
| 144 | MP0001943_abnormal_respiration | 0.53856976 |
| 145 | * MP0003632_abnormal_nervous_system | 0.52954949 |
| 146 | MP0004510_myositis | 0.52240151 |
| 147 | MP0006035_abnormal_mitochondrial_morpho | 0.51738863 |
| 148 | MP0003861_abnormal_nervous_system | 0.51705519 |
| 149 | MP0003938_abnormal_ear_development | 0.51548472 |
| 150 | MP0001765_abnormal_ion_homeostasis | 0.51166990 |
| 151 | * MP0003634_abnormal_glial_cell | 0.49406442 |
| 152 | MP0001485_abnormal_pinna_reflex | 0.49399935 |
| 153 | MP0006072_abnormal_retinal_apoptosis | 0.48017988 |
| 154 | MP0000569_abnormal_digit_pigmentation | 0.47047163 |
| 155 | MP0000015_abnormal_ear_pigmentation | 0.46941554 |
| 156 | * MP0003956_abnormal_body_size | 0.45669753 |
| 157 | MP0010770_preweaning_lethality | 0.45548558 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.78766671 |
| 2 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 6.40871267 |
| 3 | Focal seizures (HP:0007359) | 5.64907030 |
| 4 | Myokymia (HP:0002411) | 5.27107867 |
| 5 | Hyperventilation (HP:0002883) | 5.16323586 |
| 6 | Atonic seizures (HP:0010819) | 5.15071501 |
| 7 | Hypochromic microcytic anemia (HP:0004840) | 5.12414058 |
| 8 | Epileptic encephalopathy (HP:0200134) | 5.01120919 |
| 9 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.83088148 |
| 10 | Prolonged bleeding time (HP:0003010) | 4.80891714 |
| 11 | Poikilocytosis (HP:0004447) | 4.68872976 |
| 12 | Absence seizures (HP:0002121) | 4.53565081 |
| 13 | Limb dystonia (HP:0002451) | 4.52205817 |
| 14 | Gingival bleeding (HP:0000225) | 4.29130041 |
| 15 | Recurrent bacterial skin infections (HP:0005406) | 4.28737222 |
| 16 | Dialeptic seizures (HP:0011146) | 4.27929961 |
| 17 | Febrile seizures (HP:0002373) | 4.20293468 |
| 18 | Generalized tonic-clonic seizures (HP:0002069) | 3.93122641 |
| 19 | Ocular albinism (HP:0001107) | 3.93020559 |
| 20 | Slow saccadic eye movements (HP:0000514) | 3.90845051 |
| 21 | Amblyopia (HP:0000646) | 3.77529718 |
| 22 | T lymphocytopenia (HP:0005403) | 3.76902546 |
| 23 | Broad-based gait (HP:0002136) | 3.72615469 |
| 24 | Epistaxis (HP:0000421) | 3.69741150 |
| 25 | Recurrent abscess formation (HP:0002722) | 3.68757142 |
| 26 | Increased mean platelet volume (HP:0011877) | 3.62907239 |
| 27 | Progressive cerebellar ataxia (HP:0002073) | 3.62040994 |
| 28 | Acute necrotizing encephalopathy (HP:0006965) | 3.58752729 |
| 29 | Iris hypopigmentation (HP:0007730) | 3.57038282 |
| 30 | Abnormal platelet volume (HP:0011876) | 3.55761991 |
| 31 | Aplasia/Hypoplasia of the macula (HP:0008059) | 3.54820515 |
| 32 | * Visual hallucinations (HP:0002367) | 3.47012273 |
| 33 | Abnormality of T cell number (HP:0011839) | 3.43743866 |
| 34 | Microcytic anemia (HP:0001935) | 3.38815659 |
| 35 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 3.26615510 |
| 36 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.24248356 |
| 37 | Progressive macrocephaly (HP:0004481) | 3.23066184 |
| 38 | Spontaneous hematomas (HP:0007420) | 3.18928310 |
| 39 | Menorrhagia (HP:0000132) | 3.15949848 |
| 40 | Eczematoid dermatitis (HP:0000976) | 3.12256851 |
| 41 | Excessive salivation (HP:0003781) | 3.09560491 |
| 42 | Drooling (HP:0002307) | 3.09560491 |
| 43 | Anxiety (HP:0000739) | 3.08957547 |
| 44 | Truncal ataxia (HP:0002078) | 3.01184031 |
| 45 | Supranuclear gaze palsy (HP:0000605) | 2.98640838 |
| 46 | Poor eye contact (HP:0000817) | 2.94524138 |
| 47 | Neurofibrillary tangles (HP:0002185) | 2.92470248 |
| 48 | Epileptiform EEG discharges (HP:0011182) | 2.91328768 |
| 49 | Gastrointestinal infarctions (HP:0005244) | 2.90884333 |
| 50 | Conjunctival telangiectasia (HP:0000524) | 2.88353505 |
| 51 | Mitochondrial inheritance (HP:0001427) | 2.86767572 |
| 52 | Progressive inability to walk (HP:0002505) | 2.85408495 |
| 53 | Acanthocytosis (HP:0001927) | 2.84241495 |
| 54 | Petechiae (HP:0000967) | 2.82633362 |
| 55 | Inability to walk (HP:0002540) | 2.80454030 |
| 56 | Diplopia (HP:0000651) | 2.79026623 |
| 57 | Abnormality of binocular vision (HP:0011514) | 2.79026623 |
| 58 | Generalized hypopigmentation (HP:0007513) | 2.77214943 |
| 59 | Optic neuritis (HP:0100653) | 2.75547482 |
| 60 | Retrobulbar optic neuritis (HP:0100654) | 2.75547482 |
| 61 | Pheochromocytoma (HP:0002666) | 2.75276224 |
| 62 | Hemiplegia (HP:0002301) | 2.73905343 |
| 63 | Papillary thyroid carcinoma (HP:0002895) | 2.73425156 |
| 64 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.71414347 |
| 65 | Acute encephalopathy (HP:0006846) | 2.70731516 |
| 66 | Hypochromic anemia (HP:0001931) | 2.70414600 |
| 67 | Gaze-evoked nystagmus (HP:0000640) | 2.68054523 |
| 68 | EEG with generalized epileptiform discharges (HP:0011198) | 2.66204690 |
| 69 | Stomatitis (HP:0010280) | 2.65145142 |
| 70 | Papilledema (HP:0001085) | 2.65087344 |
| 71 | Gait imbalance (HP:0002141) | 2.60454719 |
| 72 | Absent speech (HP:0001344) | 2.59960236 |
| 73 | Depression (HP:0000716) | 2.59745562 |
| 74 | Neuroendocrine neoplasm (HP:0100634) | 2.57594748 |
| 75 | Impaired social interactions (HP:0000735) | 2.57074011 |
| 76 | Abnormal social behavior (HP:0012433) | 2.57074011 |
| 77 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.55360515 |
| 78 | Resting tremor (HP:0002322) | 2.54822041 |
| 79 | Recurrent fungal infections (HP:0002841) | 2.54126886 |
| 80 | Insidious onset (HP:0003587) | 2.50838532 |
| 81 | Termporal pattern (HP:0011008) | 2.50838532 |
| 82 | Protruding tongue (HP:0010808) | 2.49930224 |
| 83 | Dysmetria (HP:0001310) | 2.49432080 |
| 84 | Myositis (HP:0100614) | 2.46483596 |
| 85 | Recurrent skin infections (HP:0001581) | 2.44314108 |
| 86 | Orchitis (HP:0100796) | 2.43247918 |
| 87 | Cholelithiasis (HP:0001081) | 2.42038553 |
| 88 | Hypsarrhythmia (HP:0002521) | 2.41546826 |
| 89 | Gingivitis (HP:0000230) | 2.40452505 |
| 90 | Arterial thrombosis (HP:0004420) | 2.37797643 |
| 91 | Increased CSF lactate (HP:0002490) | 2.35407349 |
| 92 | Bradykinesia (HP:0002067) | 2.35257149 |
| 93 | Purpura (HP:0000979) | 2.33944968 |
| 94 | Action tremor (HP:0002345) | 2.33303599 |
| 95 | Dysdiadochokinesis (HP:0002075) | 2.32154479 |
| 96 | Chest pain (HP:0100749) | 2.30636224 |
| 97 | Medial flaring of the eyebrow (HP:0010747) | 2.30359192 |
| 98 | Hemiparesis (HP:0001269) | 2.28866212 |
| 99 | Abnormality of saccadic eye movements (HP:0000570) | 2.27231679 |
| 100 | Congenital primary aphakia (HP:0007707) | 2.24506096 |
| 101 | Abnormal eating behavior (HP:0100738) | 2.23910310 |
| 102 | Leukocytosis (HP:0001974) | 2.21213454 |
| 103 | Polycythemia (HP:0001901) | 2.20602509 |
| 104 | Optic disc pallor (HP:0000543) | 2.19431877 |
| 105 | Abnormal gallbladder morphology (HP:0012437) | 2.18404879 |
| 106 | Polyphagia (HP:0002591) | 2.18008257 |
| 107 | Keratoconjunctivitis sicca (HP:0001097) | 2.17308710 |
| 108 | Generalized myoclonic seizures (HP:0002123) | 2.15693116 |
| 109 | * Cerebral inclusion bodies (HP:0100314) | 2.15257358 |
| 110 | Psychosis (HP:0000709) | 2.15175782 |
| 111 | Abnormality of salivation (HP:0100755) | 2.14098071 |
| 112 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.13262734 |
| 113 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.13033440 |
| 114 | Hypothermia (HP:0002045) | 2.12710322 |
| 115 | Encephalitis (HP:0002383) | 2.11654266 |
| 116 | Subacute progressive viral hepatitis (HP:0006572) | 2.11540760 |
| 117 | Abnormality of the corticospinal tract (HP:0002492) | 2.11337878 |
| 118 | Impaired smooth pursuit (HP:0007772) | 2.10916413 |
| 119 | Fetal akinesia sequence (HP:0001989) | 2.10481218 |
| 120 | Retinal dysplasia (HP:0007973) | 2.07709086 |
| 121 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.07650383 |
| 122 | Nephrogenic diabetes insipidus (HP:0009806) | 2.07209986 |
| 123 | Mutism (HP:0002300) | 2.06684344 |
| 124 | Peritonitis (HP:0002586) | 2.04192316 |
| 125 | Urticaria (HP:0001025) | 2.03569565 |
| 126 | Hypoventilation (HP:0002791) | 2.02166772 |
| 127 | Blue irides (HP:0000635) | 2.01655314 |
| 128 | Genital tract atresia (HP:0001827) | 2.00241066 |
| 129 | * Delusions (HP:0000746) | 2.00064587 |
| 130 | Abnormal gallbladder physiology (HP:0012438) | 1.98751942 |
| 131 | Cholecystitis (HP:0001082) | 1.98751942 |
| 132 | Keratoconjunctivitis (HP:0001096) | 1.98695489 |
| 133 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.97584213 |
| 134 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.97584213 |
| 135 | Vaginal atresia (HP:0000148) | 1.96909031 |
| 136 | X-linked dominant inheritance (HP:0001423) | 1.96764922 |
| 137 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.96133694 |
| 138 | Absent/shortened dynein arms (HP:0200106) | 1.96133694 |
| 139 | Abnormal hair whorl (HP:0010721) | 1.96017969 |
| 140 | Abnormality of T cells (HP:0002843) | 1.95940982 |
| 141 | Hepatocellular necrosis (HP:0001404) | 1.95900458 |
| 142 | Amyotrophic lateral sclerosis (HP:0007354) | 1.95494931 |
| 143 | Hyperthyroidism (HP:0000836) | 1.94870201 |
| 144 | Gastroesophageal reflux (HP:0002020) | 1.93487695 |
| 145 | Stereotypic behavior (HP:0000733) | 1.92717923 |
| 146 | Thyroid carcinoma (HP:0002890) | 1.92609350 |
| 147 | Abnormal auditory evoked potentials (HP:0006958) | 1.90938703 |
| 148 | Episodic fever (HP:0001954) | 1.90380738 |
| 149 | Abnormality of macrophages (HP:0004311) | 1.89780491 |
| 150 | Increased hepatocellular lipid droplets (HP:0006565) | 1.89750896 |
| 151 | Ankle clonus (HP:0011448) | 1.88560224 |
| 152 | Urinary urgency (HP:0000012) | 1.88358153 |
| 153 | Abnormality of the lower motor neuron (HP:0002366) | 1.88164847 |
| 154 | Fair hair (HP:0002286) | 1.87846173 |
| 155 | Obstructive lung disease (HP:0006536) | 1.86605987 |
| 156 | Chronic obstructive pulmonary disease (HP:0006510) | 1.86605987 |
| 157 | Hypoplasia of the fovea (HP:0007750) | 1.86323949 |
| 158 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.86323949 |
| 159 | Generalized hypopigmentation of hair (HP:0011358) | 1.85185149 |
| 160 | Gait ataxia (HP:0002066) | 1.84923292 |
| 161 | Rigidity (HP:0002063) | 1.84077395 |
| 162 | Vertigo (HP:0002321) | 1.84003658 |
| 163 | Paresthesia (HP:0003401) | 1.83999467 |
| 164 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.83902130 |
| 165 | Recurrent cutaneous fungal infections (HP:0011370) | 1.83902130 |
| 166 | Spastic gait (HP:0002064) | 1.83623285 |
| 167 | Genetic anticipation (HP:0003743) | 1.83346639 |
| 168 | Poor suck (HP:0002033) | 1.83239443 |
| 169 | Status epilepticus (HP:0002133) | 1.83106129 |
| 170 | Abnormal ciliary motility (HP:0012262) | 1.82939114 |
| 171 | Thickened helices (HP:0000391) | 1.82902241 |
| 172 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.82321863 |
| 173 | Postural instability (HP:0002172) | 1.82158990 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.97335662 |
| 2 | NTRK3 | 4.10703924 |
| 3 | MAP3K12 | 3.76988366 |
| 4 | CASK | 3.62236752 |
| 5 | MAP3K4 | 3.36076993 |
| 6 | RIPK4 | 3.29014456 |
| 7 | MAP2K7 | 3.15709991 |
| 8 | MAP3K9 | 3.02699811 |
| 9 | FRK | 2.78196489 |
| 10 | PNCK | 2.70645201 |
| 11 | MINK1 | 2.55216506 |
| 12 | BLK | 2.43131053 |
| 13 | MARK1 | 2.40674589 |
| 14 | DAPK2 | 2.29719350 |
| 15 | MAP2K4 | 2.25456283 |
| 16 | MAP2K3 | 2.12533614 |
| 17 | ARAF | 2.10459440 |
| 18 | DAPK1 | 2.07392906 |
| 19 | NME1 | 2.00046644 |
| 20 | EIF2AK1 | 1.99852784 |
| 21 | TAOK3 | 1.89990580 |
| 22 | * SYK | 1.73498800 |
| 23 | BMPR2 | 1.70224739 |
| 24 | CDK19 | 1.68896910 |
| 25 | IKBKE | 1.66514556 |
| 26 | KSR1 | 1.66125141 |
| 27 | STK4 | 1.62395293 |
| 28 | KSR2 | 1.61405739 |
| 29 | SGK3 | 1.55929572 |
| 30 | SIK2 | 1.55747242 |
| 31 | WNK1 | 1.51868255 |
| 32 | ERBB2 | 1.50108340 |
| 33 | CSK | 1.49900795 |
| 34 | MAP3K11 | 1.44725359 |
| 35 | TEC | 1.44164683 |
| 36 | NTRK2 | 1.43342723 |
| 37 | MARK3 | 1.42236497 |
| 38 | TAOK1 | 1.42151511 |
| 39 | BTK | 1.39622389 |
| 40 | CDK5 | 1.38484318 |
| 41 | MAP3K13 | 1.35076860 |
| 42 | MAPK13 | 1.33385917 |
| 43 | NTRK1 | 1.32143845 |
| 44 | * CAMK2A | 1.29631827 |
| 45 | CAMK2B | 1.27332570 |
| 46 | * PLK2 | 1.27116528 |
| 47 | FES | 1.26076907 |
| 48 | PRKCG | 1.25417009 |
| 49 | PAK6 | 1.23410944 |
| 50 | TXK | 1.22450751 |
| 51 | PIK3CG | 1.21129445 |
| 52 | IRAK4 | 1.18506250 |
| 53 | IRAK2 | 1.14830715 |
| 54 | PIM1 | 1.12986197 |
| 55 | TNIK | 1.12024174 |
| 56 | MARK2 | 1.10748349 |
| 57 | HCK | 1.10456008 |
| 58 | ACVR1B | 1.08108117 |
| 59 | MAPKAPK5 | 1.07618015 |
| 60 | FGFR3 | 1.06899812 |
| 61 | YES1 | 1.06188309 |
| 62 | OXSR1 | 1.04278171 |
| 63 | ZAP70 | 1.03910698 |
| 64 | JAK2 | 1.02167583 |
| 65 | MAP3K3 | 1.00543543 |
| 66 | MAP3K5 | 0.99924549 |
| 67 | JAK3 | 0.98723300 |
| 68 | GRK7 | 0.97948452 |
| 69 | RAF1 | 0.97273316 |
| 70 | CSNK1G2 | 0.96607698 |
| 71 | CDK18 | 0.94460950 |
| 72 | PRPF4B | 0.93749544 |
| 73 | CDK14 | 0.93680909 |
| 74 | JAK1 | 0.92907503 |
| 75 | CDK15 | 0.89683531 |
| 76 | * LYN | 0.87603520 |
| 77 | BMX | 0.86963487 |
| 78 | ITK | 0.84581532 |
| 79 | PINK1 | 0.84496265 |
| 80 | CAMKK2 | 0.83015859 |
| 81 | MAP4K1 | 0.81584165 |
| 82 | CAMK2D | 0.81242980 |
| 83 | ADRBK2 | 0.80300493 |
| 84 | CDK11A | 0.79454118 |
| 85 | IRAK1 | 0.78474135 |
| 86 | CAMKK1 | 0.78289022 |
| 87 | MAP3K6 | 0.77934595 |
| 88 | LATS2 | 0.73425735 |
| 89 | MATK | 0.72791564 |
| 90 | UHMK1 | 0.71606872 |
| 91 | PRKCH | 0.70728376 |
| 92 | CCNB1 | 0.69840004 |
| 93 | PRKCE | 0.68806900 |
| 94 | SIK3 | 0.66909047 |
| 95 | CAMK4 | 0.65138599 |
| 96 | BRAF | 0.65135374 |
| 97 | CSNK1G3 | 0.64088861 |
| 98 | FER | 0.63618639 |
| 99 | AKT3 | 0.63320639 |
| 100 | LCK | 0.62343084 |
| 101 | NEK6 | 0.60541054 |
| 102 | MAP3K2 | 0.59506867 |
| 103 | SGK1 | 0.59097224 |
| 104 | BCR | 0.59034401 |
| 105 | CAMK2G | 0.59028593 |
| 106 | TYK2 | 0.58484386 |
| 107 | RET | 0.58095515 |
| 108 | CAMK1 | 0.57082085 |
| 109 | PHKG2 | 0.56487113 |
| 110 | PHKG1 | 0.56487113 |
| 111 | EGFR | 0.56020390 |
| 112 | PAK3 | 0.55955557 |
| 113 | * GRK5 | 0.55866596 |
| 114 | MYLK | 0.55811488 |
| 115 | * FYN | 0.55438768 |
| 116 | ROCK2 | 0.55224225 |
| 117 | TAOK2 | 0.54901545 |
| 118 | FGFR2 | 0.54824362 |
| 119 | SGK223 | 0.54019906 |
| 120 | SGK494 | 0.54019906 |
| 121 | MAP2K1 | 0.53655870 |
| 122 | STK11 | 0.51935095 |
| 123 | DAPK3 | 0.51771241 |
| 124 | STK38 | 0.50161719 |
| 125 | MAP3K14 | 0.50103637 |
| 126 | TYRO3 | 0.48889033 |
| 127 | PRKD1 | 0.48770840 |
| 128 | MAPK12 | 0.47296540 |
| 129 | MUSK | 0.47206297 |
| 130 | CSF1R | 0.47059199 |
| 131 | PRKCZ | 0.45204805 |
| 132 | MOS | 0.44844383 |
| 133 | * PTK2B | 0.43600360 |
| 134 | PRKACA | 0.40794655 |
| 135 | BMPR1B | 0.38343141 |
| 136 | IKBKB | 0.38172600 |
| 137 | STK39 | 0.37533999 |
| 138 | PDK4 | 0.36558337 |
| 139 | PDK3 | 0.36558337 |
| 140 | PDPK1 | 0.35245406 |
| 141 | MAP3K1 | 0.34946715 |
| 142 | TSSK6 | 0.34775045 |
| 143 | WNK3 | 0.34670955 |
| 144 | SGK2 | 0.32187831 |
| 145 | PRKCB | 0.31684977 |
| 146 | PRKCQ | 0.30770673 |
| 147 | RPS6KA3 | 0.30319349 |
| 148 | WNK4 | 0.29947842 |
| 149 | PRKD3 | 0.29889635 |
| 150 | PRKCA | 0.29442007 |
| 151 | TNK2 | 0.29421783 |
| 152 | PDK1 | 0.29328058 |
| 153 | * DYRK1A | 0.29206339 |
| 154 | PKN1 | 0.28117647 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.14967546 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.43304121 |
| 3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.96711091 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.92037676 |
| 5 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.91666563 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.87901552 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.66709185 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.58803995 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 2.54229364 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.43187086 |
| 11 | GABAergic synapse_Homo sapiens_hsa04727 | 2.43161774 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.41056131 |
| 13 | Morphine addiction_Homo sapiens_hsa05032 | 2.40547622 |
| 14 | Platelet activation_Homo sapiens_hsa04611 | 2.15813767 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 2.11801475 |
| 16 | Salivary secretion_Homo sapiens_hsa04970 | 2.10836440 |
| 17 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.05130530 |
| 18 | Parkinsons disease_Homo sapiens_hsa05012 | 2.02206436 |
| 19 | Alzheimers disease_Homo sapiens_hsa05010 | 1.98709792 |
| 20 | Renin secretion_Homo sapiens_hsa04924 | 1.98269722 |
| 21 | Cocaine addiction_Homo sapiens_hsa05030 | 1.86172730 |
| 22 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.83013317 |
| 23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.76823308 |
| 24 | Long-term depression_Homo sapiens_hsa04730 | 1.75095853 |
| 25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.73542286 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.71206206 |
| 27 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.69534466 |
| 28 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.69166036 |
| 29 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.68804452 |
| 30 | Insulin secretion_Homo sapiens_hsa04911 | 1.64878826 |
| 31 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.57340500 |
| 32 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.56827065 |
| 33 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.55926877 |
| 34 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.55530419 |
| 35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.51536966 |
| 36 | Leishmaniasis_Homo sapiens_hsa05140 | 1.47310626 |
| 37 | Huntingtons disease_Homo sapiens_hsa05016 | 1.42837063 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.38979911 |
| 39 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.37748262 |
| 40 | Malaria_Homo sapiens_hsa05144 | 1.37439475 |
| 41 | Tuberculosis_Homo sapiens_hsa05152 | 1.35973922 |
| 42 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.34036588 |
| 43 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.33647987 |
| 44 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.33051712 |
| 45 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.31665804 |
| 46 | Gap junction_Homo sapiens_hsa04540 | 1.30268679 |
| 47 | Phototransduction_Homo sapiens_hsa04744 | 1.29187301 |
| 48 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.26438162 |
| 49 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.21882276 |
| 50 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.18842640 |
| 51 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.10477577 |
| 52 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.04708708 |
| 53 | Axon guidance_Homo sapiens_hsa04360 | 1.03717333 |
| 54 | Endometrial cancer_Homo sapiens_hsa05213 | 1.01321290 |
| 55 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.99321713 |
| 56 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.97486433 |
| 57 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.97396720 |
| 58 | Melanogenesis_Homo sapiens_hsa04916 | 0.95856293 |
| 59 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.94246007 |
| 60 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.93838402 |
| 61 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.93535901 |
| 62 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.93462638 |
| 63 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.92661191 |
| 64 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91261530 |
| 65 | Glioma_Homo sapiens_hsa05214 | 0.89057076 |
| 66 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.88210229 |
| 67 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.87666538 |
| 68 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.85043371 |
| 69 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.84852289 |
| 70 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.83684179 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83482320 |
| 72 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.82986747 |
| 73 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.82569755 |
| 74 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.80802858 |
| 75 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.78158950 |
| 76 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.76712525 |
| 77 | Alcoholism_Homo sapiens_hsa05034 | 0.75208819 |
| 78 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.74927356 |
| 79 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.73685513 |
| 80 | Measles_Homo sapiens_hsa05162 | 0.72981249 |
| 81 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.72756292 |
| 82 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.71452634 |
| 83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71077613 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.71023722 |
| 85 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.70202173 |
| 86 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.69358829 |
| 87 | Hepatitis B_Homo sapiens_hsa05161 | 0.67261985 |
| 88 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.67222091 |
| 89 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.66641938 |
| 90 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.66617043 |
| 91 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.65551696 |
| 92 | Legionellosis_Homo sapiens_hsa05134 | 0.64794827 |
| 93 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.63616506 |
| 94 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.62811346 |
| 95 | Apoptosis_Homo sapiens_hsa04210 | 0.62306134 |
| 96 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.61639218 |
| 97 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.59983616 |
| 98 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.59770050 |
| 99 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.59031983 |
| 100 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.58912123 |
| 101 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57671942 |
| 102 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.55746885 |
| 103 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.54328136 |
| 104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51141661 |
| 105 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.49003713 |
| 106 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.48574868 |
| 107 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48251382 |
| 108 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47677268 |
| 109 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.46715272 |
| 110 | Phagosome_Homo sapiens_hsa04145 | 0.44034565 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.42973380 |
| 112 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.42833809 |
| 113 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42509861 |
| 114 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.42313756 |
| 115 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41635850 |
| 116 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40387815 |
| 117 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34072896 |
| 118 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.33255064 |
| 119 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32358300 |
| 120 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.32034866 |
| 121 | Prion diseases_Homo sapiens_hsa05020 | 0.30195613 |
| 122 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.30004460 |
| 123 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.29238790 |
| 124 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.29221758 |
| 125 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.27992801 |
| 126 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.27835705 |
| 127 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.25483422 |
| 128 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.21981217 |
| 129 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.20632062 |
| 130 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.17277142 |
| 131 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.13773778 |
| 132 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.12529694 |
| 133 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.12457432 |
| 134 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.12113356 |
| 135 | Circadian rhythm_Homo sapiens_hsa04710 | 0.11453516 |
| 136 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.11373807 |
| 137 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.11043650 |
| 138 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.10995518 |
| 139 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.10097689 |
| 140 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.07958023 |

